Home
Investment
News & Views
Company News
news storage
Broker snap: Dechra continues to grow
Wed, 08 Feb, 2012
INVESTMENT NEWS
Company Search
Search QCK.COM
Investment Home
News & Views
Top Stories
Charting
Company Search
Watchlist
Market Reports
Market Buzz
Company News
Economic News
New Issues
Other News
Broker snap: Dechra continues to grow
Tue, 7 Sep 2010, 11:02:00
The buy case for veterinary products group <b>Dechra Pharmaceuticals </b>is increasingly compelling, FinnCap believes, after the group posted a 10% rise in annual profit Tuesday morning and hiked its dividend 18%. Revenue growth of 5.5% year on year was in line with FinnCap's expectations and had been signalled in the company's pre-close trading update. That means that Dechra is growing its revenues at a rate faster than the underlying market growth reported at 2-3%, FinnCap analyst Keith Redpath notes. Net debt is also on the path FinnCap expected, with the company announcing a reduction to £6.7m at the end of June from £15.5m a year earlier. "Since our initiation of coverage on 8 December 2009 at 447.9p, Dechra's shares reached a high of 505p (twice) before falling to recent lows. We reiterate our 533p price target. While other companies in the veterinary space have had issues, Dechra continues to grow," FinnCap said.
©2004-2009 QCK.com
